ACM
SPRY icon

Aquatic Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History

Aquatic Capital Management’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$111K Sell
13,855
-22,182
-62% -$213K ﹤0.01% 1085
2025
Q4 		$420K Sell
36,037
-69,714
-66% -$678K 0.01% 789
2025
Q3 		$1.06M Buy
105,751
+57,063
+117% +$819K 0.02% 656
2025
Q2 		$850K Buy
+48,688
New +$703K 0.02% 695
2024
Q2 		– Sell
-1,100
Closed -$11.2K – 1573
2024
Q1 		$11.2K Buy
+1,100
New +$8.2K ﹤0.01% 1136
2023
Q3 		– Sell
-6,900
Closed -$46K – 1620
2023
Q2 		$46K Buy
+6,900
New +$46.1K ﹤0.01% 1005

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return